ISRCTN50011192已完成不适用
A dose response study of the effects of increased fruit and vegetables intake on vascular functio
Food Standards Agency (UK)0 个研究点目标入组 48 人开始时间: 2005年9月9日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Subjects will be male or female, non-smoking and aged between 22-65 years. A principal aim is to identify and recruit subjects with moderate elevation of Blood Pressure (BP). Eligible subjects will have diastolic more than 80 mmHg and less than 100 mmHg and a systolic BP of less than 160 mmHg.
排除标准
- •1. Current smokers
- •2. A reported history of myocardial infarction or cancer
- •3. Diabetes mellitus (fasting plasma glucose more than 7 mmol/l)
- •4. Recent use of oral hypolipidaemic therapy, systemic corticosteroids, androgens, phenytoin, erythromycin or thyroid hormones
- •5. Current use of antihypertensive medication
- •6. Those receiving drugs for regulating haemostasis but excluding aspirin or who have been exposed to any investigational agent within 30 days of the study
- •7. Chronic coronary, renal or bowel disease or history of cholestatic liver disease or pancreatitis
- •8. Presence of gastrointestinal disorder or use of a drug, which is likely to alter gastrointestinal motility or nutrient absorption
- •9. History of substance abuse or alcoholism
- •10. Currently pregnant, planning pregnancy, or having had a baby in the last 12 months
- •11. Allergy or intolerance to intervention foods
- •12. Unwilling to follow the protocol and/or give informed consent
- •13. Unwilling to refrain from use of dietary supplements
- •14. Weight loss at more than 3 kg in preceding two months
- •15. Alcohol intake not exceeding a moderate intake of (less than 24 - 36 g/day)
- •16. Body Mass Index more than 20 and less than 35 kg/m^2
- •17. Subjects with a blood pressure and other risk factors that make them eligible for drug treatment of raised blood pressure according to the UK guidelines of the British Hypertension Society
研究者
相似试验
已完成
不适用
A study to evaluate the dose-response effect of tolvaptan 7.5mg or 15mg in HF patients who undergo cartdiac angiographyHeart FailureJPRN-UMIN000009924Showa University Northern Hospital100
招募中
不适用
A study for the difference in effects of high-dose prednisolone therapy for autoimmune disease patientsrheumatic disease like dermatomyositis, polymyositis, systemic lupus erythematosus, vasculitides, adult Still's disease and so on.JPRN-UMIN000007673Graduate School of Medicine Kyoto University Rheumatology and Clinical Immunology100
进行中(未招募)
1 期
Investigation of dose response relationships when using low dose naltrexone (LDN) for the treatment of fibromyalgiaFibromyalgiaMedDRA version: 20.0Level: LLTClassification code 10016631Term: Fibromyalgia syndromeSystem Organ Class: 100000004859EUCTR2016-002081-31-DKAnæstesiologisk-intensiv afd V, Odense Universitets Hospital38
进行中(未招募)
不适用
An evaluation of the dose-response relationship of Cizolirtine citrate 300 mg, twice daily, and 400 mg, twice daily, versus placebo in subjects with urge urinary incontinence.A 12-week, randomised, double-blind, placebo-controlled, multicentre study, parallel-group, Phase III clinical study with a 12 months safety follow-up period.rge Urinary IncontinenceEUCTR2004-001119-69-ESaboratorios Dr. Esteve, SA450
进行中(未招募)
1 期
An evaluation of the dose-response relationship of Cizolirtine citrate 300 mg, twice daily, and 400 mg, twice daily, versus placebo in subjects with urge urinary incontinence.A 12-week, randomised, double-blind, placebo-controlled, multicentre study, parallel-group, Phase III clinical study with a 12 months safety follow-up period.rge Urinary IncontinenceEUCTR2004-001119-69-CZaboratorios Dr. Esteve, SA450
